We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

SEC Investigates Par Pharmaceutical

Law360 (July 25, 2006, 12:00 AM EDT) -- The U.S. Securities and Exchange Commission is investigating Par Pharmaceutical Companies Inc. following the company’s July 5 announcement that it will restate its financial results for the fiscal years 2004 and...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.